Phase IIa, Randomized, Double Blinded, Placebo Controlled, Dose Finding Study for TLC599 in OA Patients
Status:
Completed
Trial end date:
2018-07-04
Target enrollment:
Participant gender:
Summary
This trial is a Phase IIa, Randomized, Double blinded, Placebo controlled, Dose finding Study
to investigate the safety and efficacy of TLC599 in subjects with osteoarthritis of the knee.